Michael Gendreau

Title: Michael Gendreau: Innovator in Fibromyalgia Treatment

Introduction

Michael Gendreau is a notable inventor based in Poway, California. He has made significant contributions to the field of medicine, particularly in the treatment of fibromyalgia syndrome. His innovative approach has led to the development of a unique method for long-term management of this challenging condition.

Latest Patents

Gendreau holds a patent for "Milnacipran for the long-term treatment of fibromyalgia syndrome." This invention focuses on methods for providing long-term treatment by administering a dual re-uptake inhibitor to patients suffering from fibromyalgia syndrome. More specifically, it involves the use of a norepinephrine-serotonin reuptake inhibitor (NSRI) to effectively manage the symptoms of this condition.

Career Highlights

Michael Gendreau is associated with Cypress Bioscience, Inc., where he has been instrumental in advancing research and development in the field of fibromyalgia treatment. His work has been pivotal in exploring new therapeutic options for patients, enhancing their quality of life.

Collaborations

Gendreau has collaborated with esteemed colleagues such as Srinivas G Rao and Jay D Kranzler. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the medical research community.

Conclusion

Michael Gendreau's contributions to the treatment of fibromyalgia syndrome through his patented methods highlight his dedication to improving patient care. His work continues to inspire advancements in medical research and treatment options.